COVID-19 resources / Clinical Research Insights and News

The Cohortias Blog

Stay informed

COVID-19 resources

Cohortias is bringing clinical research to Latin America, now proud to participate in COVID-19 clinical trials.

Our archive includes insights from our experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in Latin America and around the world.

Our blog posts provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’.


Cohortias – Positive data from Alzheimer’s disease vaccine trial

At week six, the ACI-24.060 vaccine elicited an anti-Abeta antibody response in ABATE’s first, low dose cohort of AD patients.


Cohortias – Phase I for new ulcerative colitis therapy trial

ALTB-268 helps to restore the immune system to a state of balance.


Cohortias – FDA clears to begin colorectal cancer therapy trial

The trial will enroll 44 patients who are failing prior lines of chemotherapy and who express LGR5 on cancer cells.


Cohortias – New trial for lung disease treatment

The trial will assess the efficacy and safety of pulsed inhaled nitric oxide in patients at risk for pulmonary hypertension.

COVID-19 Research - Free Consultation

The clinical development journey is fraught with pitfalls and roadblocks; COVID-19 has almost overnight added to the complexity. Innovations, technologies and reinvented processes can help. Our experienced team of experts shares experiences, lessons learned and tips to help you mitigate risk in the current environment while implementing some of the industry’s latest innovations.

covid clinical trials

The presence of clinical research in Latin America has been growing steadily for the last decade, mainly because of cost effectiveness, excellent patient recruitment and the emergence of FDA approved regulatory agencies.